Newborn Screening Market Size, Share & Trends Report

Newborn Screening Market Size, Share & Trends Analysis Report By Technology (Tandem Mass Spectrometry, Pulse Oximetry), By Test Type, By Product (Instruments, Reagents), By Region, And Segment Forecasts, 2023 - 2030

Report ID: 978-1-68038-490-1
Number of Pages: 180
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry:Healthcare

Market Segmentation

Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Tandem Mass Spectrometry
- Pulse Oximetry
- Enzyme-based Assay
- DNA Assays
- Electrophoresis
- Others
Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
- Dry Blood Spot Test
- CCHD
- Hearing Screen
Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
- Instruments
- Reagents
Newborn Screening Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Instruments
    - Reagents & Assay Kits
  - North America Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Tandem Mass Spectrometry
    - Pulse Oximetry
    - Enzyme Based Assays
    - DNA Assays
    - Electrophoresis
    - Others
  - North America Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Dry Blood Spot Test
    - Critical Congenital Heart Disease (CCHD)
    - Hearing Screen
  - U.S.
    - U.S. Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - U.S. Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - U.S. Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - Canada
    - Canada Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - Canada Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - Canada Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
- Europe
  - Europe Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Instruments
    - Reagents & Assay Kits
  - Europe Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Tandem Mass Spectrometry
    - Pulse Oximetry
    - Enzyme Based Assays
    - DNA Assays
    - Electrophoresis
    - Others
  - Europe Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Dry Blood Spot Test
    - Critical Congenital Heart Disease (CCHD)
    - Hearing Screen
  - U.K.
    - U.K. Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - U.K. Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - U.K. Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - Germany
    - Germany Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - Germany Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - Germany Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - France
    - France Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - France Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - France Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - Italy
    - Italy Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - Italy Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - Italy Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - Spain
    - Spain Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - Spain Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - Spain Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - Sweden
    - Sweden Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - Sweden Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - Sweden Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - Denmark
    - Denmark Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - Denmark Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - Denmark Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - Norway
    - Norway Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - Norway Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - Norway Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
- Asia Pacific
  - Asia Pacific Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Instruments
    - Reagents & Assay Kits
  - Asia Pacific Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Tandem Mass Spectrometry
    - Pulse Oximetry
    - Enzyme Based Assays
    - DNA Assays
    - Electrophoresis
    - Others
  - Asia Pacific Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Dry Blood Spot Test
    - Critical Congenital Heart Disease (CCHD)
    - Hearing Screen
  - Japan
    - Japan Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - Japan Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - Japan Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - 中国
    - 中国Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - 中国Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - 中国Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - India
    - India Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - India Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - India Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - Australia
    - Australia Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - Australia Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - Australia Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - 韩国
    - 韩国Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - 韩国Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - 韩国Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - Thailand
    - Thailand Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - Thailand Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - Thailand Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
- Latin America
  - Latin America Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Instruments
    - Reagents & Assay Kits
  - Latin America Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Tandem Mass Spectrometry
    - Pulse Oximetry
    - Enzyme Based Assays
    - DNA Assays
    - Electrophoresis
    - Others
  - 拉丁美洲新生儿筛查测试类型前景(Revenue, USD Million, 2018 - 2030)
    - Dry Blood Spot Test
    - Critical Congenital Heart Disease (CCHD)
    - Hearing Screen
  - Brazil
    - Brazil Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - Brazil Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - Brazil Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - Mexico
    - Mexico Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - Mexico Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - Mexico Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - Argentina
    - Argentina Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - Argentina Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - Argentina Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
- MEA
  - MEA Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
    - - Instruments
      - Reagents & Assay Kits
  - MEA Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
  - MEA Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
    - - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - South Africa
    - South Africa Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - South Africa Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - South Africa Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - Saudi Arabia
    - Saudi Arabia Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - Saudi Arabia Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - Saudi Arabia Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - UAE
    - UAE Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - UAE Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - UAE Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - Kuwait
    - Kuwait Newborn Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Reagents & Assay Kits
    - Kuwait Newborn Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
      - Others
    - Kuwait Newborn Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
乐鱼体育手机网站入口
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

需要一个自定义的报告吗?

We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.